Canadian Collaborating Clinical Trials Network for Cancer Studies
Official title: Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network
Funded at Queen's University at Kingston · NIH-11291258 · Data updated 2026-11-12
A national network in Canada coordinates advanced cancer trials with international partners to bring cutting-edge therapies to patients more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Queen's University at Kingston NIH-funded |
| Lab location | 1 site (Kingston, Canada) |
| Project start | May 6, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $182,524 |
| NIH project number | 2U10CA180863-12 |
| Project ID | NIH-11291258 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer who may participate in NCTN-aligned trials, including adults and adolescents/young adults across breast, lung, urological, and other cancer types in Canada.
✕Less likely to help
Patients not eligible for specific trials or without access to participating centers may not benefit directly.
What this research studies
This grant supports a Canadian Collaborating Clinical Trials Network (CCCTN) under the Canadian Cancer Trials Group to lead, design, and conduct multi-center cancer trials with international collaboration. It emphasizes precision medicine, rare cancers, and trials testing new drugs and cellular therapies, while strengthening trial infrastructure, data collection, and biospecimen handling. By linking Canadian patients and centers to the wider National Clinical Trials Network, the program aims to accelerate study completion and improve outcomes for people with cancer. The work includes leadership roles, trial accrual, and IT and regulatory activities essential for modern, efficient trials.
Why it matters
Potential benefit: This could speed access to innovative cancer therapies and improve outcomes for patients across Canada and beyond.
How similar studies have gone: Previous NCTN-aligned, international collaborations have advanced practice-changing trials and accelerated accrual in cancer research.
Where this research is happening
-
Queen's University at Kingston
Kingston, Canada Active
Researchers
- Principal investigator: Dancey, Janet Ellen — Queen's University at Kingston
- Study coordinator: Dancey, Janet Ellen
Related research
Other NIH-funded projects on the same topics.
-
Canadian cancer trials network for better, faster patient-ready trials
A national network in Canada partners with the US to speed up and improve cancer trials so patients get access to better treatments sooner.
-
Canadian Collaborating Clinical Trials Network for cancer care
A national network in Canada works with international partners to test new cancer drugs and cellular therapies in adults and young people to improve treatment and outcomes.
-
Canadian Collaborating Clinical Trials Network supports faster, better cancer trials for patients
A large, international cancer trials network is working with U.S. partners to run smarter, faster clinical trials so patients receive better, faster access to new therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.